Crispr Therapeutics AG (CRSP) on GreekSoup https://greeksoup.ai/stocks/us/crsp/ Every dated entry in the public record on Crispr Therapeutics AG: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Crispr Therapeutics AG: Kulkarni Samarth (Chief Executive Officer) sold 47,837 shares at $49.78 on 19 October 2026, $2.4 millionhttps://greeksoup.ai/stocks/us/crsp/insiders/us:CRSP:insider:2026-10-20:efc9be18ffTue, 20 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/crsp/filings/us:CRSP:filing:2026-10-19:4ec0f5f544Mon, 19 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: George Simeon (Director) sold 14,514 shares (under a trading plan set in advance) at $49.63 on 14 October 2026, $720,373https://greeksoup.ai/stocks/us/crsp/insiders/us:CRSP:insider:2026-10-16:6fa65b01a4Fri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Kasinger James R. (General Counsel and Secretary) sold 1,040 shares at $49.26 on 14 October 2026, $51,230https://greeksoup.ai/stocks/us/crsp/insiders/us:CRSP:insider:2026-10-15:6f5f87f754Thu, 15 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Kulkarni Samarth (Chief Executive Officer) sold 4,098 shares at $49.26 on 14 October 2026, $201,867https://greeksoup.ai/stocks/us/crsp/insiders/us:CRSP:insider:2026-10-15:9537e7f517Thu, 15 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: short interest 16,442,415 shares at the 15 October 2026 settlement, 10.23 days to coverhttps://greeksoup.ai/stocks/us/crsp/short-interest/us:CRSP:short-interest:2026-10-15:b84b1b878bThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Form 144, SIMEON GEORGE plans to sell 14,514 shares worth $720,373 around 14 October 2026https://greeksoup.ai/stocks/us/crsp/planned-sales/us:CRSP:planned-sale:2026-10-14:e03ac38482Wed, 14 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Kasinger James R. (General Counsel and Secretary) sold 1,990 shares (under a trading plan set in advance) at $60.04 on 6 October 2026, $119,481https://greeksoup.ai/stocks/us/crsp/insiders/us:CRSP:insider:2026-10-08:a681e377fdThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Form 144, JAMES KASINGER plans to sell 1,990 shares worth $119,481 around 6 October 2026https://greeksoup.ai/stocks/us/crsp/planned-sales/us:CRSP:planned-sale:2026-10-06:0e3da06f8eTue, 06 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: short interest 18,679,198 shares at the 30 September 2026 settlement, 9.58 days to coverhttps://greeksoup.ai/stocks/us/crsp/short-interest/us:CRSP:short-interest:2026-09-30:993d0607f8Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Kasinger James R. (General Counsel and Secretary) sold 10,400 shares (under a trading plan set in advance) at $60.24 on 22 September 2026, $626,460https://greeksoup.ai/stocks/us/crsp/insiders/us:CRSP:insider:2026-09-24:a2b03a6138Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Form 144, JAMES KASINGER plans to sell 10,400 shares worth $626,460 around 22 September 2026https://greeksoup.ai/stocks/us/crsp/planned-sales/us:CRSP:planned-sale:2026-09-22:fbc873569eTue, 22 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Behbahani Ali (Director) sold 13,679 shares at $57.09 on 17 September 2026, $780,935https://greeksoup.ai/stocks/us/crsp/insiders/us:CRSP:insider:2026-09-21:3e26735905Mon, 21 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Form 144, ALI BEHBAHANI plans to sell 13,679 shares worth $780,935 around 17 September 2026https://greeksoup.ai/stocks/us/crsp/planned-sales/us:CRSP:planned-sale:2026-09-17:76ad99d9efThu, 17 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: short interest 19,071,093 shares at the 15 September 2026 settlement, 16.54 days to coverhttps://greeksoup.ai/stocks/us/crsp/short-interest/us:CRSP:short-interest:2026-09-15:8e4fb485f0Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: short interest 18,769,995 shares at the 31 August 2026 settlement, 10.73 days to coverhttps://greeksoup.ai/stocks/us/crsp/short-interest/us:CRSP:short-interest:2026-08-31:fd62f4da25Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: Schedule 13G/A filed by ORBIS INVESTMENT MANAGEMENT LTD, 5.6% of the classhttps://greeksoup.ai/stocks/us/crsp/holders/us:CRSP:schedule-13:2026-08-14:81b7bcc953Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: short interest 18,744,855 shares at the 14 August 2026 settlement, 15.58 days to coverhttps://greeksoup.ai/stocks/us/crsp/short-interest/us:CRSP:short-interest:2026-08-14:ccca532b01Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG Q2 FY2026 results: revenue $10 million, net income -$91 millionhttps://greeksoup.ai/stocks/us/crsp/results/fy2026-q2/us:CRSP:result:2026-08-03:9b81b37629Mon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/crsp/filings/us:CRSP:filing:2026-08-03:70c6286a21Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/crsp/filings/us:CRSP:filing:2026-08-03:569ba04e63Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Crispr Therapeutics AG: short interest 18,815,663 shares at the 31 July 2026 settlement, 11.52 days to coverhttps://greeksoup.ai/stocks/us/crsp/short-interest/us:CRSP:short-interest:2026-07-31:cb47c9b673Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>